GATC Health
GATC Health accelerates drug discovery by using AI to predict efficacy, safety, and biological interactions so companies can advance therapeutics faster and with lower risk. It does this via its proprietary Multiomics Advanced Technology (MAT) platform, an AI-driven system that combines neural networks, machine learning, and multiomics simulation of human systems biology to identify and validate targets and predict off-target effects. The company operates as a B2B provider through SaaS, licensing, and partnerships with pharmaceutical and biotech firms, financial institutions, universities, CROs, and healthcare organizations. GATC Health has produced novel drug candidates and reports the capacity to generate up to twelve potential therapeutics per year, positioning it in the computational drug-discovery and biotech tools market.
GATC Health
GATC Health accelerates drug discovery by using AI to predict efficacy, safety, and biological interactions so companies can advance therapeutics faster and with lower risk. It does this via its proprietary Multiomics Advanced Technology (MAT) platform, an AI-driven system that combines neural networks, machine learning, and multiomics simulation of human systems biology to identify and validate targets and predict off-target effects. The company operates as a B2B provider through SaaS, licensing, and partnerships with pharmaceutical and biotech firms, financial institutions, universities, CROs, and healthcare organizations. GATC Health has produced novel drug candidates and reports the capacity to generate up to twelve potential therapeutics per year, positioning it in the computational drug-discovery and biotech tools market.
